Robert Nelsen, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 161,480 shares at $10.80 ($1.8M) on 2023-09-25, disclosed to the SEC on 2023-09-25.
Open-market purchase of $1.8M NMRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 40,000 | $446K | 24.6% |
| 2 | $10.80 | 30,773 | $332K | 18.4% |
| 3 | $10.80 | 30,773 | $332K | 18.4% |
| 4 | $11.65 | 29,967 | $349K | 19.3% |
| 5 | $11.65 | 29,967 | $349K | 19.3% |
| Total | $11.20 avg | 161,480 |
| $1.8M |
| 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |